Ivermectin induced Steven–Johnsons syndrome: case report
Abstract Background Stevens–Johnson syndrome is one of the manifestations of mucocutaneous adverse drug reactions. Although antimicrobials are responsible for greater than 50% of these adverse drug reactions, there is no documented case implicating ivermectin as the culprit. Case summary A 38 year o...
Main Authors: | Desmond Aroke, Diego Nitcheu Tchouakam, Alexis Tazinya Awungia, Sylvester Yari Mapoh, Stewart Ndutard Ngassa, Benjamin Momo Kadia |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-05-01
|
Series: | BMC Research Notes |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13104-017-2500-5 |
Similar Items
-
Steven-Johnson Syndrome
by: Pauline Joy F. Santos, et al.
Published: (2017-07-01) -
Anesthetic management and outcomes of patients with Steven-Johnson Syndrome—A retrospective review study
by: Manjula V Ramsali, et al.
Published: (2021-01-01) -
Topical Treatment for Stevens - Johnson Syndrome and Toxic Epidermal Necrolysis: A Review
by: Schandra Purnamawati, et al.
Published: (2016-08-01) -
Stevens-Johnson syndrome and toxic epidermal necrolysis in pregnant patients: A systematic review
by: Ajay N. Sharma, BS, et al.
Published: (2020-09-01) -
Epidemiology of Stevens–Johnson syndrome and toxic epidermal necrolysis in Southeast Asia
by: Haur Yueh Lee, et al.
Published: (2013-12-01)